This document is an excerpt from the EUR-Lex website
Document 62019TN0041
Case T-41/19: Action brought on 23 January 2019 — MSI Svetovanje v EUIPO — Industrial Farmaceutica Cantabria (nume)
Case T-41/19: Action brought on 23 January 2019 — MSI Svetovanje v EUIPO — Industrial Farmaceutica Cantabria (nume)
Case T-41/19: Action brought on 23 January 2019 — MSI Svetovanje v EUIPO — Industrial Farmaceutica Cantabria (nume)
IO C 112, 25.3.2019, p. 42–43
(BG, ES, CS, DA, DE, ET, EL, EN, FR, HR, IT, LV, LT, HU, MT, NL, PL, PT, RO, SK, SL, FI, SV)
25.3.2019 |
EN |
Official Journal of the European Union |
C 112/42 |
Action brought on 23 January 2019 — MSI Svetovanje v EUIPO — Industrial Farmaceutica Cantabria (nume)
(Case T-41/19)
(2019/C 112/51)
Language of the case: English
Parties
Applicant: MSI Svetovanje, marketing, d.o.o (Vrhnika, Slovenia) (represented by: M. Maček, lawyer)
Defendant: European Union Intellectual Property Office (EUIPO)
Other party to the proceedings before the Board of Appeal: Industrial Farmaceutica Cantabria, SA (Madrid, Spain)
Details of the proceedings before EUIPO
Applicant of the trade mark at issue: Applicant before the General Court
Trade mark at issue: Application for European Union figurative nume — Application for registration No 15 120 355
Procedure before EUIPO: Opposition proceedings
Contested decision: Decision of the Fifth Board of Appeal of EUIPO of 8 November 2018 in Case R 722/2018-5
Form of order sought
The applicant claims that the Court should:
— |
annul the contested decision; |
— |
order EUIPO to bear its own costs and to pay those incurred to MSI Svetovanje d.o.o. |
Pleas in law
— |
Infringement of Article 95(1) of Regulation (EU) 2017/1001 of the European Parliament and of the Council; |
— |
Infringement of Article 94 of Regulation (EU) 2017/1001 of the European Parliament and of the Council and of Article 296 of the Treaty on the Functioning of the European Union; |
— |
Infringement of Articles 8(1)(b) and 8(5) of Regulation (EU) 2017/1001 of the European Parliament and of the Council. |